The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Albendazole Drug Market Research Report 2025
Synopsis
Albendazole is a medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken by mouth.
The global Albendazole Drug market was valued at US$ 159.1 million in 2023 and is anticipated to reach US$ 267.2 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Albendazole Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole Drug.
Report Scope
The Albendazole Drug market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albendazole Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albendazole Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Hubei Zhongjia-Chem Pharmaceutical
Hubei Keyi Pharmaceutical
Changzhou Yabang
Huazhong Pharmaceutical
Sequent Scientific
K.A.Malle Pharmaceuticals
Fredun Pharmaceuticals
Ashish Life Science
AdvaCare Pharma
Segment by Type
Capsule
Tablet
Segment by Application
Giardiasis
Trichuriasis
Filariasis
Neurocysticercosis
Hydatid Disease
Pinworm Disease
Ascariasis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albendazole Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albendazole Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Albendazole is a medication used for the treatment of a variety of parasitic worm infestations. It is useful for giardiasis, trichuriasis, filariasis, neurocysticercosis, hydatid disease, pinworm disease, and ascariasis, among others. It is taken by mouth.
The global Albendazole Drug market was valued at US$ 159.1 million in 2023 and is anticipated to reach US$ 267.2 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Albendazole Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albendazole Drug.
Report Scope
The Albendazole Drug market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Albendazole Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albendazole Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Hubei Zhongjia-Chem Pharmaceutical
Hubei Keyi Pharmaceutical
Changzhou Yabang
Huazhong Pharmaceutical
Sequent Scientific
K.A.Malle Pharmaceuticals
Fredun Pharmaceuticals
Ashish Life Science
AdvaCare Pharma
Segment by Type
Capsule
Tablet
Segment by Application
Giardiasis
Trichuriasis
Filariasis
Neurocysticercosis
Hydatid Disease
Pinworm Disease
Ascariasis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Albendazole Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Albendazole Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Albendazole Drug Market Overview
1.1 Product Overview and Scope of Albendazole Drug
1.2 Albendazole Drug Segment by Type
1.2.1 Global Albendazole Drug Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Tablet
1.3 Albendazole Drug Segment by Application
1.3.1 Global Albendazole Drug Market Value by Application: (2024-2030)
1.3.2 Giardiasis
1.3.3 Trichuriasis
1.3.4 Filariasis
1.3.5 Neurocysticercosis
1.3.6 Hydatid Disease
1.3.7 Pinworm Disease
1.3.8 Ascariasis
1.3.9 Other
1.4 Global Albendazole Drug Market Size Estimates and Forecasts
1.4.1 Global Albendazole Drug Revenue 2019-2030
1.4.2 Global Albendazole Drug Sales 2019-2030
1.4.3 Global Albendazole Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Albendazole Drug Market Competition by Manufacturers
2.1 Global Albendazole Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Albendazole Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Albendazole Drug Average Price by Manufacturers (2019-2024)
2.4 Global Albendazole Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Albendazole Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Albendazole Drug, Product Type & Application
2.7 Albendazole Drug Market Competitive Situation and Trends
2.7.1 Albendazole Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Albendazole Drug Players Market Share by Revenue
2.7.3 Global Albendazole Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Albendazole Drug Retrospective Market Scenario by Region
3.1 Global Albendazole Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Albendazole Drug Global Albendazole Drug Sales by Region: 2019-2030
3.2.1 Global Albendazole Drug Sales by Region: 2019-2024
3.2.2 Global Albendazole Drug Sales by Region: 2025-2030
3.3 Global Albendazole Drug Global Albendazole Drug Revenue by Region: 2019-2030
3.3.1 Global Albendazole Drug Revenue by Region: 2019-2024
3.3.2 Global Albendazole Drug Revenue by Region: 2025-2030
3.4 North America Albendazole Drug Market Facts & Figures by Country
3.4.1 North America Albendazole Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Albendazole Drug Sales by Country (2019-2030)
3.4.3 North America Albendazole Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Albendazole Drug Market Facts & Figures by Country
3.5.1 Europe Albendazole Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Albendazole Drug Sales by Country (2019-2030)
3.5.3 Europe Albendazole Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Albendazole Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Albendazole Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Albendazole Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Albendazole Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Albendazole Drug Market Facts & Figures by Country
3.7.1 Latin America Albendazole Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Albendazole Drug Sales by Country (2019-2030)
3.7.3 Latin America Albendazole Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Albendazole Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Albendazole Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Albendazole Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Albendazole Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Albendazole Drug Sales by Type (2019-2030)
4.1.1 Global Albendazole Drug Sales by Type (2019-2024)
4.1.2 Global Albendazole Drug Sales by Type (2025-2030)
4.1.3 Global Albendazole Drug Sales Market Share by Type (2019-2030)
4.2 Global Albendazole Drug Revenue by Type (2019-2030)
4.2.1 Global Albendazole Drug Revenue by Type (2019-2024)
4.2.2 Global Albendazole Drug Revenue by Type (2025-2030)
4.2.3 Global Albendazole Drug Revenue Market Share by Type (2019-2030)
4.3 Global Albendazole Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Albendazole Drug Sales by Application (2019-2030)
5.1.1 Global Albendazole Drug Sales by Application (2019-2024)
5.1.2 Global Albendazole Drug Sales by Application (2025-2030)
5.1.3 Global Albendazole Drug Sales Market Share by Application (2019-2030)
5.2 Global Albendazole Drug Revenue by Application (2019-2030)
5.2.1 Global Albendazole Drug Revenue by Application (2019-2024)
5.2.2 Global Albendazole Drug Revenue by Application (2025-2030)
5.2.3 Global Albendazole Drug Revenue Market Share by Application (2019-2030)
5.3 Global Albendazole Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Albendazole Drug Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Hubei Zhongjia-Chem Pharmaceutical
6.2.1 Hubei Zhongjia-Chem Pharmaceutical Corporation Information
6.2.2 Hubei Zhongjia-Chem Pharmaceutical Description and Business Overview
6.2.3 Hubei Zhongjia-Chem Pharmaceutical Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hubei Zhongjia-Chem Pharmaceutical Albendazole Drug Product Portfolio
6.2.5 Hubei Zhongjia-Chem Pharmaceutical Recent Developments/Updates
6.3 Hubei Keyi Pharmaceutical
6.3.1 Hubei Keyi Pharmaceutical Corporation Information
6.3.2 Hubei Keyi Pharmaceutical Description and Business Overview
6.3.3 Hubei Keyi Pharmaceutical Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hubei Keyi Pharmaceutical Albendazole Drug Product Portfolio
6.3.5 Hubei Keyi Pharmaceutical Recent Developments/Updates
6.4 Changzhou Yabang
6.4.1 Changzhou Yabang Corporation Information
6.4.2 Changzhou Yabang Description and Business Overview
6.4.3 Changzhou Yabang Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changzhou Yabang Albendazole Drug Product Portfolio
6.4.5 Changzhou Yabang Recent Developments/Updates
6.5 Huazhong Pharmaceutical
6.5.1 Huazhong Pharmaceutical Corporation Information
6.5.2 Huazhong Pharmaceutical Description and Business Overview
6.5.3 Huazhong Pharmaceutical Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Huazhong Pharmaceutical Albendazole Drug Product Portfolio
6.5.5 Huazhong Pharmaceutical Recent Developments/Updates
6.6 Sequent Scientific
6.6.1 Sequent Scientific Corporation Information
6.6.2 Sequent Scientific Description and Business Overview
6.6.3 Sequent Scientific Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sequent Scientific Albendazole Drug Product Portfolio
6.6.5 Sequent Scientific Recent Developments/Updates
6.7 K.A.Malle Pharmaceuticals
6.6.1 K.A.Malle Pharmaceuticals Corporation Information
6.6.2 K.A.Malle Pharmaceuticals Description and Business Overview
6.6.3 K.A.Malle Pharmaceuticals Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 K.A.Malle Pharmaceuticals Albendazole Drug Product Portfolio
6.7.5 K.A.Malle Pharmaceuticals Recent Developments/Updates
6.8 Fredun Pharmaceuticals
6.8.1 Fredun Pharmaceuticals Corporation Information
6.8.2 Fredun Pharmaceuticals Description and Business Overview
6.8.3 Fredun Pharmaceuticals Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fredun Pharmaceuticals Albendazole Drug Product Portfolio
6.8.5 Fredun Pharmaceuticals Recent Developments/Updates
6.9 Ashish Life Science
6.9.1 Ashish Life Science Corporation Information
6.9.2 Ashish Life Science Description and Business Overview
6.9.3 Ashish Life Science Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ashish Life Science Albendazole Drug Product Portfolio
6.9.5 Ashish Life Science Recent Developments/Updates
6.10 AdvaCare Pharma
6.10.1 AdvaCare Pharma Corporation Information
6.10.2 AdvaCare Pharma Description and Business Overview
6.10.3 AdvaCare Pharma Albendazole Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AdvaCare Pharma Albendazole Drug Product Portfolio
6.10.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Albendazole Drug Industry Chain Analysis
7.2 Albendazole Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Albendazole Drug Production Mode & Process
7.4 Albendazole Drug Sales and Marketing
7.4.1 Albendazole Drug Sales Channels
7.4.2 Albendazole Drug Distributors
7.5 Albendazole Drug Customers
8 Albendazole Drug Market Dynamics
8.1 Albendazole Drug Industry Trends
8.2 Albendazole Drug Market Drivers
8.3 Albendazole Drug Market Challenges
8.4 Albendazole Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Albendazole Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Albendazole Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Albendazole Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Albendazole Drug Sales (Ton) of Key Manufacturers (2019-2024)
Table 5. Global Albendazole Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Albendazole Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Albendazole Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Albendazole Drug Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Albendazole Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Albendazole Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Albendazole Drug, Product Type & Application
Table 12. Global Key Manufacturers of Albendazole Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Albendazole Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albendazole Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Albendazole Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Albendazole Drug Sales by Region (2019-2024) & (Ton)
Table 18. Global Albendazole Drug Sales Market Share by Region (2019-2024)
Table 19. Global Albendazole Drug Sales by Region (2025-2030) & (Ton)
Table 20. Global Albendazole Drug Sales Market Share by Region (2025-2030)
Table 21. Global Albendazole Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Albendazole Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Albendazole Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Albendazole Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Albendazole Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Albendazole Drug Sales by Country (2019-2024) & (Ton)
Table 27. North America Albendazole Drug Sales by Country (2025-2030) & (Ton)
Table 28. North America Albendazole Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Albendazole Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Albendazole Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Albendazole Drug Sales by Country (2019-2024) & (Ton)
Table 32. Europe Albendazole Drug Sales by Country (2025-2030) & (Ton)
Table 33. Europe Albendazole Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Albendazole Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Albendazole Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Albendazole Drug Sales by Region (2019-2024) & (Ton)
Table 37. Asia Pacific Albendazole Drug Sales by Region (2025-2030) & (Ton)
Table 38. Asia Pacific Albendazole Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Albendazole Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Albendazole Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Albendazole Drug Sales by Country (2019-2024) & (Ton)
Table 42. Latin America Albendazole Drug Sales by Country (2025-2030) & (Ton)
Table 43. Latin America Albendazole Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Albendazole Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Albendazole Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Albendazole Drug Sales by Country (2019-2024) & (Ton)
Table 47. Middle East & Africa Albendazole Drug Sales by Country (2025-2030) & (Ton)
Table 48. Middle East & Africa Albendazole Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Albendazole Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Albendazole Drug Sales (Ton) by Type (2019-2024)
Table 51. Global Albendazole Drug Sales (Ton) by Type (2025-2030)
Table 52. Global Albendazole Drug Sales Market Share by Type (2019-2024)
Table 53. Global Albendazole Drug Sales Market Share by Type (2025-2030)
Table 54. Global Albendazole Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Albendazole Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Albendazole Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Albendazole Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Albendazole Drug Price (US$/Ton) by Type (2019-2024)
Table 59. Global Albendazole Drug Price (US$/Ton) by Type (2025-2030)
Table 60. Global Albendazole Drug Sales (Ton) by Application (2019-2024)
Table 61. Global Albendazole Drug Sales (Ton) by Application (2025-2030)
Table 62. Global Albendazole Drug Sales Market Share by Application (2019-2024)
Table 63. Global Albendazole Drug Sales Market Share by Application (2025-2030)
Table 64. Global Albendazole Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Albendazole Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Albendazole Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Albendazole Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Albendazole Drug Price (US$/Ton) by Application (2019-2024)
Table 69. Global Albendazole Drug Price (US$/Ton) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline Albendazole Drug Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Hubei Zhongjia-Chem Pharmaceutical Corporation Information
Table 76. Hubei Zhongjia-Chem Pharmaceutical Description and Business Overview
Table 77. Hubei Zhongjia-Chem Pharmaceutical Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Hubei Zhongjia-Chem Pharmaceutical Albendazole Drug Product
Table 79. Hubei Zhongjia-Chem Pharmaceutical Recent Developments/Updates
Table 80. Hubei Keyi Pharmaceutical Corporation Information
Table 81. Hubei Keyi Pharmaceutical Description and Business Overview
Table 82. Hubei Keyi Pharmaceutical Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Hubei Keyi Pharmaceutical Albendazole Drug Product
Table 84. Hubei Keyi Pharmaceutical Recent Developments/Updates
Table 85. Changzhou Yabang Corporation Information
Table 86. Changzhou Yabang Description and Business Overview
Table 87. Changzhou Yabang Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Changzhou Yabang Albendazole Drug Product
Table 89. Changzhou Yabang Recent Developments/Updates
Table 90. Huazhong Pharmaceutical Corporation Information
Table 91. Huazhong Pharmaceutical Description and Business Overview
Table 92. Huazhong Pharmaceutical Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Huazhong Pharmaceutical Albendazole Drug Product
Table 94. Huazhong Pharmaceutical Recent Developments/Updates
Table 95. Sequent Scientific Corporation Information
Table 96. Sequent Scientific Description and Business Overview
Table 97. Sequent Scientific Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Sequent Scientific Albendazole Drug Product
Table 99. Sequent Scientific Recent Developments/Updates
Table 100. K.A.Malle Pharmaceuticals Corporation Information
Table 101. K.A.Malle Pharmaceuticals Description and Business Overview
Table 102. K.A.Malle Pharmaceuticals Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. K.A.Malle Pharmaceuticals Albendazole Drug Product
Table 104. K.A.Malle Pharmaceuticals Recent Developments/Updates
Table 105. Fredun Pharmaceuticals Corporation Information
Table 106. Fredun Pharmaceuticals Description and Business Overview
Table 107. Fredun Pharmaceuticals Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Fredun Pharmaceuticals Albendazole Drug Product
Table 109. Fredun Pharmaceuticals Recent Developments/Updates
Table 110. Ashish Life Science Corporation Information
Table 111. Ashish Life Science Description and Business Overview
Table 112. Ashish Life Science Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Ashish Life Science Albendazole Drug Product
Table 114. Ashish Life Science Recent Developments/Updates
Table 115. AdvaCare Pharma Corporation Information
Table 116. AdvaCare Pharma Description and Business Overview
Table 117. AdvaCare Pharma Albendazole Drug Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. AdvaCare Pharma Albendazole Drug Product
Table 119. AdvaCare Pharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Albendazole Drug Distributors List
Table 123. Albendazole Drug Customers List
Table 124. Albendazole Drug Market Trends
Table 125. Albendazole Drug Market Drivers
Table 126. Albendazole Drug Market Challenges
Table 127. Albendazole Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Albendazole Drug
Figure 2. Global Albendazole Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Albendazole Drug Market Share by Type in 2023 & 2030
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Albendazole Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Albendazole Drug Market Share by Application in 2023 & 2030
Figure 8. Giardiasis
Figure 9. Trichuriasis
Figure 10. Filariasis
Figure 11. Neurocysticercosis
Figure 12. Hydatid Disease
Figure 13. Pinworm Disease
Figure 14. Ascariasis
Figure 15. Other
Figure 16. Global Albendazole Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Albendazole Drug Market Size (2019-2030) & (US$ Million)
Figure 18. Global Albendazole Drug Sales (2019-2030) & (Ton)
Figure 19. Global Albendazole Drug Average Price (US$/Ton) & (2019-2030)
Figure 20. Albendazole Drug Report Years Considered
Figure 21. Albendazole Drug Sales Share by Manufacturers in 2023
Figure 22. Global Albendazole Drug Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Albendazole Drug Players: Market Share by Revenue in 2023
Figure 24. Albendazole Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Albendazole Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Albendazole Drug Sales Market Share by Country (2019-2030)
Figure 27. North America Albendazole Drug Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Albendazole Drug Sales Market Share by Country (2019-2030)
Figure 31. Europe Albendazole Drug Revenue Market Share by Country (2019-2030)
Figure 32. Germany Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Albendazole Drug Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Albendazole Drug Revenue Market Share by Region (2019-2030)
Figure 39. China Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Albendazole Drug Sales Market Share by Country (2019-2030)
Figure 50. Latin America Albendazole Drug Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Albendazole Drug Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Albendazole Drug Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. UAE Albendazole Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Albendazole Drug by Type (2019-2030)
Figure 60. Global Revenue Market Share of Albendazole Drug by Type (2019-2030)
Figure 61. Global Albendazole Drug Price (US$/Ton) by Type (2019-2030)
Figure 62. Global Sales Market Share of Albendazole Drug by Application (2019-2030)
Figure 63. Global Revenue Market Share of Albendazole Drug by Application (2019-2030)
Figure 64. Global Albendazole Drug Price (US$/Ton) by Application (2019-2030)
Figure 65. Albendazole Drug Value Chain
Figure 66. Albendazole Drug Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
